GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
Rating: FMS
Overweight

Fresenius Medical Care Corporation (NYSE: FMS) rated to Overweight by Morgan Stanley

Tuesday,  Dec 3, 2013  9:25 AM ET by Lynn Gilbert

Morgan Stanley rated
Fresenius Medical Care Corporation (NYSE: FMS) to Overweight.

Fresenius Medical Care AG & Co. KGaA (FMC-AG & Co. KGaA), is a kidney dialysis company, operating in both the field of dialysis products and the field of dialysis services. The Company?s dialysis business is vertically integrated, providing dialysis treatment at its own dialysis clinics and supplying these clinics with a range of products. In addition, the Company sells dialysis products to other dialysis service providers. At December 31, 2008, it provided dialysis treatment to 184,086 patients in 2,388 clinics worldwide located in more than 30 countries. In the United States, it also performs clinical laboratory testing and provides inpatient dialysis services and other services under contract to hospitals. During the year ended December 31, 2008, it provided 27.9 million dialysis treatments. It also develops and manufactures a range of equipments, systems and disposable products, which it sells to customers in over 115 countries.

Morgan Stanley Investment Research is one of the financial industry's dominant thought leaders in equity and fixed-income investing. Our analysts, economists, and strategists have earned this reputation through timely, in-depth analysis of companies, industries, markets, and the world’s economies. Our teams collaborate to assist Morgan Stanley clients with investment decisions, using cash and derivative instruments across major asset classes and geographies.



RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy